文献速递临床试验与 GCP

比较新斯的明与舒更葡糖对术后残余肌松和术后肺部并发症的影响:基于膈肌与肺超声的前瞻性双盲随机对照试验研究方案

Comparison of the effects of neostigmine and sugammadex on postoperative residual curarization and postoperative pulmonary complications by means of diaphragm and lung ultrasonography: a study protocol for prospective double-blind randomized controlled trial.
PubMed 文献 · Trials · 2022-05-07

本研究为前瞻性双盲随机对照试验,拟纳入60岁以上、美国麻醉医师协会体能状态I-III级、全身麻醉下接受关节置换术的患者,随机分为新斯的明组和舒更葡糖组,用于逆转罗库溴铵。主要结局为两组术后肺部并发症的发生率,次要结局为独立超声医师在麻醉前及拔管后10分钟和30分钟于麻醉后监护室进行膈肌超声和肺超声的评估。

要点

  • 术后残余肌松可能是术后肺部并发症的潜在危险因素,两者均对患者康复造成不良影响。
  • 研究拟比较新斯的明与舒更葡糖对术后残余肌松和术后肺部并发症的影响,采用膈肌与肺超声评估。
  • 主要结局为术后肺部并发症发生率,次要结局为膈肌超声和肺超声评估。

核心结论

  • 研究假设舒更葡糖较新斯的明更有利于降低术后肺部并发症发生率,并强烈有利于膈肌功能恢复。

研究设计与样本

  • 前瞻性、双盲、随机对照试验,纳入美国麻醉医师协会体能状态I-III级、年龄超过60岁、拟在全身麻醉下接受关节置换术的患者,随机分为新斯的明组和舒更葡糖组,用于逆转罗库溴铵。

关键数值与推荐

  • 主要结局为术后肺部并发症在NEO组和SUG组的发生率。
  • 次要结局为独立超声医师在麻醉前及拔管后10分钟和30分钟于麻醉后监护室进行的膈肌超声和肺超声评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative residual curarization (PORC) may be a potential risk factor of postoperative pulmonary complications (PPCs), and both of them will lead to adverse consequences on surgical patient recovery. The train-of-four ratio (TOFr) which is detected by acceleromyography of the adductor pollicis is thought as the gold standard for the measurement of PORC. However, diaphragm function recovery may differ from that of the peripheral muscles. Recent studies suggested that diaphragm ultrasonography may be useful to reveal the diaphragm function recovery, and similarly, lung ultrasound was reported for the assessment of PPCs in recent years as well. Sugammadex reversal of neuromuscular blockade is rapid and complete, and there appear to be fewer postoperative complications than with neostigmine. This study aims to compare the effects of neostigmine and sugammadex, on PORC and PPCs employing diaphragm and lung ultrasonography, respectively. METHODS/DESIGN: In this prospective, double-blind, randomized controlled trial, patients of the American Society of Anesthesiologists Physical Status I-III, aged over 60, will be enrolled. They will be scheduled to undergo arthroplasty under general anesthesia. All patients will be allocated randomly into two groups, group NEO (neostigmine) and group SUG (sugammadex), using these two drugs for reversing rocuronium. The primary outcome of the study is the incidence of PPCs in the NEO and SUG groups. The secondary outcomes are the evaluation of diaphragm ultrasonography and lung ultrasound, performed by an independent sonographer before anesthesia, and at 10 min and 30 min after extubation in the post-anesthesia care unit, respectively. DISCUSSION: Elimination of PORC is a priority at the emergence of anesthesia, and it may be associated with reducing postoperative complications like PPCs. Sugammadex was reported to be superior to reverse neuromuscular blockade than neostigmine. Theoretically, complete recovery of neuromuscular function should be indicated by TOFr > 0.9. However, the diaphragm function recovery may not be the same matter, which probably harms pulmonary function. The hypothesis will be proposed that sugammadex is more beneficial than neostigmine to reduce the incidence of PPCs and strongly favorable for the recovery of diaphragm function in our study setting. TRIAL REGISTRATION: ClinicalTrials.gov NCT05040490 . Registered on 3 September 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhang YG, Chen Y, Zhang YL, et al. Comparison of the effects of neostigmine and sugammadex on postoperative residual curarization and postoperative pulmonary complications by means of diaphragm and lung ultrasonography: a study protocol for prospective double-blind randomized controlled trial. Trials. 2022. PMID: 35526047. doi:10.1186/s13063-022-06328-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。